Patients
| Country | Value | Year |
|---|---|---|
| Iraq | 90 | 2019 |
| Jordan | 39 | 2019 |
| Lebanon | 59 | 2019 |
| Qatar | 91 | 2019 |
| Saudi Arabia | 91 | 2019 |
| Syria | 95 | 2019 |
| UAE | 70 | 2019 |
| Yemen | 186 | 2019 |
Updated
Reviewed by Vidhi Upadhyay
Middle East Climate-Sensitive Disease Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Disease, Test, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$126.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $113.2 Mn | — | — |
| 2025 (base) | $122.5 Mn | +$9.3 Mn | — |
| 2026 (forecast) | $132.5 Mn | +$10.0 Mn | +8.2% |
| 2027 (forecast) | $143.4 Mn | +$10.9 Mn | +17.1% |
| 2028 (forecast) | $155.1 Mn | +$11.8 Mn | +26.7% |
| 2029 (forecast) | $167.8 Mn | +$12.7 Mn | +37.1% |
| 2030 (forecast) | $181.6 Mn | +$13.8 Mn | +48.3% |
| 2031 (forecast) | $196.5 Mn | +$14.9 Mn | +60.5% |
| 2032 (forecast) | $212.6 Mn | +$16.1 Mn | +73.6% |
| 2033 (forecast) | $230.0 Mn | +$17.4 Mn | +87.9% |
| 2034 (forecast) | $248.9 Mn | +$18.9 Mn | +103.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $122.5 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $248.9 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Disease and test (see all) |
| Key players | Abbott Laboratories, SD Biosensor, bioMérieux SA, Qiagen N.V., Molbio Diagnostics (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Climate-sensitive disease diagnostics detect illnesses spreading with climate change, such as dengue, malaria, cholera and heat illness.
Key segments of the climate-Sensitive Disease Diagnostics market include disease (Dengue, Malaria and Cholera) and test (Rapid Tests and Molecular Tests).
More heatwaves, air pollution, floods and the spread of climate-sensitive diseases are driving the climate-Sensitive Disease Diagnostics market. Health systems are under pressure to cut their own emissions.
Early warning systems, greener hospitals and climate-resilient supply chains give the climate-Sensitive Disease Diagnostics market strong room to grow.
Limited dedicated funding, unclear responsibility between agencies and lack of local data hold back the climate-Sensitive Disease Diagnostics market.
The climate-Sensitive Disease Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medical devices are regulated by SFDA (Saudi Arabia)[1] and EDE (UAE)[2]. How care is paid for in some of these countries: free public care and CHI-regulated insurance (Saudi Arabia)[3] and mandatory health insurance (UAE)[4].
[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.
[2] Emirates Drug Establishment. Checked 14 Nov 2026.
[3] Council of Health Insurance. Checked 14 Nov 2026.
[4] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how climate-Sensitive Disease Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Middle East.
What doctors and scientists are doing in Climate-Sensitive Disease Diagnostics right now, from free public sources.
| Country | Value | Year |
|---|---|---|
| Iraq | 90 | 2019 |
| Jordan | 39 | 2019 |
| Lebanon | 59 | 2019 |
| Qatar | 91 | 2019 |
| Saudi Arabia | 91 | 2019 |
| Syria | 95 | 2019 |
| UAE | 70 | 2019 |
| Yemen | 186 | 2019 |
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 16 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Middle East · 2 shared keywords
Middle East · 1 shared keyword
Middle East · 1 shared keyword
Middle East
Middle East
Middle East
Digital Health · Middle East
Healthcare Services · Middle East
Pharmaceuticals · Middle East
OTC & Nutraceuticals · Middle East
Pharmaceuticals · Middle East
Healthcare Services · Middle East